Professor | Bingzheng Shen | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Bingzheng Shen
Contact Information	bzshen@whu.edu.cn
Language ability	Chinese, English
Province	Hubei

Upload Avatar (500 x 500)

Name

Bingzheng Shen

Contact Information

bzshen@whu.edu.cn

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	2001-2005: Bachelor in Pharmaceutical Preparations, China Pharmaceutical University 2009-2012: Master in Pharmacy, China Pharmaceutical University 2015-2018: PhD in Virology, Wuhan University
Work Experience	2005-2007: Assistant Engineer, Hubei Modern Traditional Chinese Medicine Engineering Technology Research Center 2012-2015: Pharmacist, Wuhan University People's Hospital 2015-2018: Chief Pharmacist, Wuhan University People's Hospital 2018-present: Vice Director Pharmacist, Wuhan University People's Hospital 2019-present: Associate Professor/Master's Supervisor, First Clinical College of Wuhan University
Awards	2022: First Prize for Scientific and Technological Progress in Hubei Province (R05) - Mechanism and Precision Treatment of Primary Liver Cancer 2014: Third Prize for Scientific and Technological Progress in Hubei Province (R05) - Research and Application of Key Technologies for Solid Preparations of New Traditional Chinese Medicine

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

2001-2005: Bachelor in Pharmaceutical Preparations, China Pharmaceutical University
2009-2012: Master in Pharmacy, China Pharmaceutical University
2015-2018: PhD in Virology, Wuhan University

Work Experience

2005-2007: Assistant Engineer, Hubei Modern Traditional Chinese Medicine Engineering Technology Research Center
2012-2015: Pharmacist, Wuhan University People's Hospital
2015-2018: Chief Pharmacist, Wuhan University People's Hospital
2018-present: Vice Director Pharmacist, Wuhan University People's Hospital
2019-present: Associate Professor/Master's Supervisor, First Clinical College of Wuhan University

Awards

2022: First Prize for Scientific and Technological Progress in Hubei Province (R05) - Mechanism and Precision Treatment of Primary Liver Cancer
2014: Third Prize for Scientific and Technological Progress in Hubei Province (R05) - Research and Application of Key Technologies for Solid Preparations of New Traditional Chinese Medicine

Areas of Focus	Discovery, pharmacological mechanisms, and delivery research of peptide drugs Rational clinical medication and precision treatment
Publications	Injectable cold atmospheric plasma-activated immunotherapeutic hydrogel for enhanced cancer treatment, Fang T, Cao X, Shen B, Chen Z, Chen G, 2023 Tick peptides evoke itch by activating MrgprC11/MRGPRX1 to sensitize TRPV1 in pruriceptors, Li X, Yang H, Han Y, Yin S, Shen B, Wu Y, Li W, Cao Z, 2021 Purlisin, a toxin-like defensin derived from clinical pathogenic fungus Purpureocillium lilacinum with both antimicrobial and potassium channel inhibitory activities, Shen B, Cao Z, Wu Y, Yi W, Zhu Z, Lv Z, Zhu C, Yu Y, 2020 Wuchang Fangcang Shelter Hospital: Practices, Experiences, and Lessons Learned in Controlling COVID-19, Shen B, Chen L, Zhang L, Zhang M, Li J, Wu J, Chen K, Xiong Y, Song W, Zhou B, 2020 Triintsin, a human pathogenic fungus-derived defensin with broad-spectrum antimicrobial activity, Shen B, Zhao Y, Zhang Y, Liu G, Li X, Guo X, Li W, Cao Z, Wu Y, 2018 Treating autoimmune disorders with venom-derived peptides, Shen B, Cao Z, Li W, Sabatier JM, Wu Y, 2017

Areas of Focus

Discovery, pharmacological mechanisms, and delivery research of peptide drugs
Rational clinical medication and precision treatment

Publications

Injectable cold atmospheric plasma-activated immunotherapeutic hydrogel for enhanced cancer treatment, Fang T, Cao X, Shen B, Chen Z, Chen G*, 2023
Tick peptides evoke itch by activating MrgprC11/MRGPRX1 to sensitize TRPV1 in pruriceptors, Li X, Yang H, Han Y, Yin S, Shen B, Wu Y, Li W, Cao Z*, 2021
Purlisin, a toxin-like defensin derived from clinical pathogenic fungus Purpureocillium lilacinum with both antimicrobial and potassium channel inhibitory activities, Shen B, Cao Z, Wu Y, Yi W, Zhu Z, Lv Z, Zhu C, Yu Y*, 2020
Wuchang Fangcang Shelter Hospital: Practices, Experiences, and Lessons Learned in Controlling COVID-19, Shen B, Chen L, Zhang L, Zhang M, Li J, Wu J, Chen K, Xiong Y, Song W, Zhou B*, 2020
Triintsin, a human pathogenic fungus-derived defensin with broad-spectrum antimicrobial activity, Shen B, Zhao Y, Zhang Y, Liu G, Li X, Guo X, Li W, Cao Z*, Wu Y*, 2018
Treating autoimmune disorders with venom-derived peptides, Shen B, Cao Z, Li W, Sabatier JM*, Wu Y*, 2017

Peptides Drug Discovery Pharmacology Drug Delivery Clinical Medication Precision Medicine Therapeutics Pharmaceutical Research Clinical Trials Drug Development

Yongmei Liu - Wuhan University

Jianying Huang - Wuhan University

Jianyuan Wu - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us